Commercialization of University Inventions
The event held on February 21, 2020 was sponsored by Mason Bioengineering Alliance and the Office of Technology Transfer.
See the meeting agenda and our sponsors' presentations:
- “Nondilutive Funding Landscape” by Vizma Carver, Founder and CEO, Carver Global Health Group
- “Ceres Nanosciences: Licensing University IP and Building a Company” by Ross M. Dunlap, CEO, Ceres Nanosciences
- “CSA Medical: From License to Company Sale” by Richard Hughen, CEO, Linshom & Principal: Life Science Planning
- “Overview of Technology Transfer and Commercialization at Mason” by Hina Mehta, Director, Office of Technology Transfer
- “SPGlobal: a Current Example of a Successful SIBR Pitch” by Eric Vollmecke, Executive VP, SPGlobal
- “Funding Mechanisms from Center for Innovative Technology” by Nancy Vorona, VP Research Investment, Center for Innovative Technology
- “Neuroparticle Corporation: Image-guided therapy with Magnetic Particles” by Elaine Wang, Founder and CEO, Neuroparticle